Zhejiang Hisun Pharmaceutical Hits Day Low Amid Price Pressure, Reaches CNY 9.41

Zhejiang Hisun Pharmaceutical Co., Ltd. experienced a significant decline in its stock price today, dropping by 7.86% and reaching an intraday low of CNY 9.41. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Zhejiang Hisun's stock has decreased by 10.55%, while its monthly performance mirrors the daily decline, also at 7.86%. Year-to-date, the stock has seen a slight decrease of 3.94%. In a longer-term view, the stock has faced challenges, with a three-year performance down by 11.46% and a five-year decline of 40.92%. Despite these recent setbacks, the company maintains a market capitalization of CNY 11,262 million and a price-to-earnings ratio of 25.00. The firm also boasts a return on equity of 6.78% and a dividend yield of 2.25%, indicating some level of financial stability within the pharmaceuticals and biotechnology sector.